Tennessee Oncology, PLLC/The Sarah Cannon Research Institute ( Site 1230) is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Tennessee Oncology, PLLC/The Sarah Cannon Research Institute ( Site 1230) has participated in 1 clinical trials.
Therapeutic areas: Small Cell Lung Cancer (SCLC).
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tennessee Oncology, PLLC/The Sarah Cannon Research Institute ( Site 1230) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tennessee Oncology, PLLC/The Sarah Cannon Research Institute ( Site 1230) has 1 clinical trials on record. Their work covers Small Cell Lung Cancer (SCLC).
Tennessee Oncology, PLLC/The Sarah Cannon Research Institute ( Site 1230) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.